Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(10%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_4
1
10%
Ph not_applicable
1
10%
Ph phase_2
4
40%
Ph phase_3
2
20%
Ph early_phase_1
1
10%

Phase Distribution

1

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 2Efficacy & side effects
4(44.4%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(7)
Other(2)

Detailed Status

Completed7
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 24 (44.4%)
Phase 32 (22.2%)
Phase 41 (11.1%)
N/A1 (11.1%)

Trials by Status

unknown220%
completed770%
active_not_recruiting110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DEVICE
Total Trials
10